GEO Group: sells Adelanto complex for $950,000,000

What happened

• The GEO Group, Inc. reported that on Oct 2, 2026 it and CPT Operating Partnership, L.P. entered into a Purchase and Sale Agreement with the United States of America, by and through the Department of Homeland Security, and sold the Adelanto West ICE Processing Center (1,280 beds), the Adelanto East ICE Processing Center (660 beds), and the Desert View Annex (704 beds) for an aggregate purchase price of $950,000,000. The sale closed concurrently with the agreement.
• The filing says the Company anticipates receiving approximately $705,000,000 in net proceeds after federal and state taxes and transaction fees and expenses. The Company states it intends to use the net proceeds along with cashflow from operations to reduce debt, repurchase shares of common stock, and for other general corporate purposes.
• The filing states the Company expects to continue providing support services for the three Adelanto facilities under its existing contract with U.S. Immigration and Customs Enforcement, which has a full term effective through Dec 19, 2034 (including the current term ending Dec 19, 2029 and a five-year option period), but notes ICE may terminate the contract for non-appropriation or for convenience.

Key details

• Aggregate purchase price: $950,000,000; expected net proceeds: approximately $705,000,000.
• Facilities and capacities: Adelanto West 1,280 beds; Adelanto East 660 beds; Desert View Annex 704 beds; location: Adelanto, California.
• Agreement date and closing: Oct 2, 2026; press release and related disclosures filed Oct 5, 2026.
• Board action: on Oct 5, 2026 the Board approved increasing the share repurchase authorization from $500,000,000 to $1,250,000,000, effective through Dec 31, 2029.

Why it may matter

• The filing reports Item 1.01 (entry into a material definitive agreement), Item 2.01 (completion of disposition of assets), Item 7.01 (regulation FD disclosure via press release) and Item 8.01 (increase in share repurchase authorization).
• The filing includes forward-looking statements and a cautionary note listing risks and uncertainties that could affect actual results, including the Company’s ability to repurchase shares, deleverage, or complete any additional asset sales to ICE. The filing does not show why the company acted.